Results 31 to 40 of about 9,154 (183)
Pain at intrauterine device placement in a Brazilian center
International Journal of Gynecology &Obstetrics, EarlyView.Abstract Objective This study explores pain at intrauterine device (IUD) placement in a large Brazilian cohort. Methods We undertook a cross‐sectional analysis of health records from individuals aged 18 to 45 years who underwent IUD placements between 2022 and 2024 at the Department of Obstetrics and Gynecology, Universidade Estadual de Campinas ...
Ana Luiza Savi +4 more
wiley +1 more source
Advances in management of uterine myomas [PDF]
Frontiers in Bioscience, 2013 Uterine myomas, the most common benign solid pelvic tumors in women, occur in twenty percent of them in reproductive years and form the most common indication for hysterectomy. Various factors affect the choice of the best treatment modality for a given patient. Asymptomatic myomas may be managed by careful follow up. Medical therapy should be tried as
openaire +2 more sources
Membranous dysmenorrhea and decidual casts: A scoping review
International Journal of Gynecology &Obstetrics, EarlyView.Abstract Background Membranous dysmenorrhea, characterized by the expulsion of intact endometrial tissue rather than gradual dissolution during menstruation, occasionally presents as a decidual cast—a complete triangular mold of the uterine cavity. This poorly understood condition is likely underdiagnosed.
Lovisa Brehmer, Hedvig Engberg
wiley +1 more source
Medical Treatment for Uterine Myomas
Taiwanese Journal of Obstetrics and Gynecology, 2008 Uterine myomas are the most common benign tumors in the female reproductive tract. Most women with myomas are asymptomatic. Therefore, expectant observation and follow-up are often recommended for these myoma patients. However, myomas may cause menstrual symptoms, pelvic pain, pressure complaints, subfertility or pregnancy-related complications, with ...
Ming-Hui Cheng +2 more
openaire +3 more sources
Uterine myoma. Non-surgical treatment [PDF]
РМЖ. Мать и дитя, 2018 Uterine myoma. Non-surgical treatment Dobrokhotova Yu.E., Ilyina I.Yu., Goncharov I.Yu. Pirogov Russian National Research Medical University, Moscow Uterine myoma occupies one of the leading positions in the structure of gynecological ...
Yu.E. Dobrokhotova +2 more
doaj
Journal of Clinical Ultrasound, EarlyView.Ultrasound may aid in the preoperative diagnosis of torsed pedunculated subserosal uterine leiomyomas (TPSUL), a rare but urgent condition. This study identifies consistent sonographic features across 42 cases, supporting ultrasound as a valuable diagnostic tool and highlighting the need for standardization in TPSUL imaging.
Maddalena Paoli +5 more
wiley +1 more source
Acta Obstetricia et Gynecologica Scandinavica, EarlyView.Magnetic resonance‐guided high‐intensity focused ultrasound (MR‐HIFU) resulted in significant symptom reduction and improved quality of life in patients with symptomatic uterine fibroids and either bleeding or bulk symptoms. When successful, MR‐HIFU provides effective and rapid symptom relief for both symptom types.
Saara Otonkoski +8 more
wiley +1 more source
Organ-preserving surgical treatment of giant uterine myoma in a pregnant woman
Вестник хирургии имени И.И. Грекова, 2020 Uterine myoma is the most common benign disease in the women of the reproductive period. According to different authors, the rate of uterine myoma in pregnancy is estimated from 0.1 to 12.5 %. We present the case of successful laparotomy myomectomy at 14–
I. E. Khatkov +3 more
doaj +1 more source
Biomarkers of the type of recurrent uterine myoma-associated growth
Медицинский вестник Юга России, 2021 Objective: To assess the diagnostic value of biomarkers: microbiological, molecular and biological, immunological biomarkers, characteristic of various types of recurrent myoma-associated growth.Materials and Methods: Seventy women of reproductive age ...
E. V. Bashirov +2 more
doaj +1 more source
Selenium‐Based Nanoplatforms: An Emerging Theranostic Paradigm for Gynecological Cancers
Advanced Science, Volume 13, Issue 33, 15 June 2026.This reivew summarizes Selenium as a multifunctional anticancer regulator in gynecological cancers. It reduces tumor risk, enhances therapeutic efficacy, and reduces treatment toxicity. Selenium also overcomes chemoraditherapy resistance, improving overall treatment outcomes. ABSTRACT Gynecological cancers present significant therapeutic challenges due
Hejing Liu +9 more
wiley +1 more source